CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results For The Quarter And Half-Year Ended September 30, 2024

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2035.7000 69.60 (3.54%)

NSE Oct 01, 2025 13:52 PM

27.31% Gain from 52W Low

Volume: 49,977

Caplin Point Laboratories Ltd.

07 Nov 2024

2035.70

3.54%

Board Meeting

CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results For The Quarter …

BSE India

Financial Results for the quarter and half-year ended September 30, 2024 is enclosed

More from Caplin Point Laboratories Ltd.

Recommended

Market trades higher, Pfizer receives 3-year tariff relief from the US Government

Trendlyne Marketwatch | 01 Oct 2025, 01:41PM

Five stocks to buy from analysts this week - September 30, 2025

The Baseline | 30 Sep 2025, 05:42PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets